ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1477

Overweight and Obesity Are Associated with Reduced Risk of Rheumatoid Arthritis in Men, but Not in Women

Carl Turesson1, Ulf Bergström2, Mitra Pikwer2,3, Jan-Åke Nilsson2 and Lennart Jacobsson2,4, 1Section of Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 2Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 3Rheumatology Unit, Mälar Hospital, Eskilstuna, Sweden, 4Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: obesity and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose There are diverging results on the relation between body mass index (BMI) and risk of rheumatoid arthritis (RA). Several studies have reported different patterns in men and women. Our purpose was to investigate the impact of overweight and obesity on the risk of RA in a prospective study.

Methods Between 1991 and 1996, 30447 subjects (12121 men; 18326 women) were included in a population based health survey. Height and weight were measured, and life style factors were assessed using a questionnaire. From this population, we identified individuals who developed RA after inclusion by linkage to 4 different RA registers. In a structured review of the medical records, patients were classified according to the 1987 American College of Rheumatology criteria for RA. Four controls for each validated case, matched for sex, year of birth and year of screening, who were alive and free of  RA when the index person was diagnosed with RA, were selected from the health survey database. The impact of overweight or obesity (BMI > 25 kg/m2) compared to normal BMI (18.5-25 kg/m2) on the risk of RA was examined in conditional logistic regression models, stratified by sex.

Results A total of 172 patients (36 men/136 women, mean age at RA diagnosis 63 years) were diagnosed with RA after inclusion in the health survey. The median time from inclusion to RA diagnosis was 5 years (range 1–13).  A total of 51 % of cases and controls combined were overweight or obese. Being overweight or obese at inclusion in the health survey was associated with a reduced risk of subsequent development of RA in men [odds ratio (OR) 0.33; 95 % confidence interval (CI) 0.14-0.76], but not in women (OR 1.01; 95 % CI 0.65-1.54). Men who fulfilled the WHO definition for obesity (BMI >30 kg/m2) had a significantly decreased risk of RA compared to those with normal BMI (OR 0.08; 95 % CI 0.01-0.67), and there was a similar trend for those with overweight (BMI 25-30 kg/m2) (OR 0.42; 95 % CI 0.17-1.00). Smoking was a significant predictor of RA in both sexes, and negatively associated with overweight/obesity in men. The estimated impact of overweight/obesity on the risk of RA in men was similar in analyses adjusted for smoking (OR 0.37; 95 % CI 0.16-0.87) and analyses adjusted for smoking, level of education and alcohol use (OR 0.37; 95 % CI 0.13-1.04). In women, overweight/obesity had no effect on the risk of RA in multivariate analyses.

Conclusion Being overweight or obese was associated with a reduced risk of future RA in men. This pattern did not appear to be explained by differences in smoking, education or alcohol use. There was no such association in women. Factors related to adipose tissue may contribute to mechanisms that are protective from RA in men.


Disclosure:

C. Turesson,
None;

U. Bergström,
None;

M. Pikwer,
None;

J. Nilsson,
None;

L. Jacobsson,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/overweight-and-obesity-are-associated-with-reduced-risk-of-rheumatoid-arthritis-in-men-but-not-in-women/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology